• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Clinical study with Spectacillin on patients with infections of the urogenital system (author's transl)].

作者信息

Bauer K M, Otto G

出版信息

Med Klin. 1975 May 2;70(18):817-21.

PMID:806772
Abstract

Report is given of clinical experiences gained with the new developed semi-syntheticpenicillin "Spectacillin" on 75 patients suffering from an urological disease. The drug has been applied for therapy of acute and chronic forms of inflammations of the bladder and the urethra, additionally the prostatitis, the epididymitis, but first of all the pyelonephritis (caused bacterially). Within the germ spectrum of these diseases, germs of the coli-type, streptococcus faecalis (enterococcus), staphylococcus aureus, Neisseria gonorrhoeae, proteus, pseudomonas and aerobacter were found. Patients with acute/subacute diseases have been treated 8 to 9 days (3-4 grams per day) on an average; in case of chronic diseases, the patients received initially 1 gram a day and thereupon during 3 to 4 weeks 3 to 4 grams per day. The well-succeeded results have been documentated by means of the clinical course, the germ-elimination and the laboratory findings. The exanthematous quote may be demonstrated as remarkably low, considering the good universal compatibility of the substance. For this reason "Spectacillin" not finally is suitable for treatment of acute and chronic infections of the urogenital systems.

摘要

相似文献

1
[Clinical study with Spectacillin on patients with infections of the urogenital system (author's transl)].
Med Klin. 1975 May 2;70(18):817-21.
2
[Treatment of urinary tract infections using pivampicillin].[使用匹氨西林治疗尿路感染]
Munch Med Wochenschr. 1972 Sep 29;114(39):1659-63.
3
[Nifurpipone in inflammatory diseases of the urinary tract].
Minerva Urol. 1973 May-Jun;25(3):149-57.
4
[Therapy results with nalidixic acid in chronic urinary tract infection].[萘啶酸治疗慢性尿路感染的疗效]
Arzneimittelforschung. 1968 Sep;18(9):1139-43.
5
[Clinical evaluation of cefazedon on patients with urinary tract infections (author's transl)].头孢替坦对尿路感染患者的临床评价(作者译)
Med Klin. 1979 May 25;74(21):834-8.
6
[Pharmacokinetic and clinical research of a new phenyl ester of carbecinillin: carfecillin].[羧苄青霉素一种新的苯酯:羧苄青霉素苯酯的药代动力学及临床研究]
Minerva Med. 1979 Jul 14;70(32):2255-64.
7
[Clinical report of treatment of urinary tract infections with lividomycin].
Jpn J Antibiot. 1972 Dec;25(6):389-95.
8
[Treatment with oxolinic acid of urinary tract infections].
Minerva Med. 1979 Jul 21;70(33):2333-9.
9
[Effectiveness of levofloxacin (Tavanik, "Aventis Pharma") in the treatment of complicated infections of the urogenital organs].
Urologiia. 2003 Jan-Feb(1):31-4.
10
Cephalexin monohydrate in the treatment of urinary tract infections and urethritis.一水头孢氨苄治疗尿路感染和尿道炎。
Prensa Med Mex. 1970 Sep-Oct:56-60.